BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7999066)

  • 1. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.
    Vacca A; Farina M; Maroder M; Alesse E; Screpanti I; Frati L; Gulino A
    Biochem Biophys Res Commun; 1994 Nov; 205(1):467-74. PubMed ID: 7999066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.
    Ott M; Lovett JL; Mueller L; Verdin E
    J Immunol; 1998 Mar; 160(6):2872-80. PubMed ID: 9510190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
    Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
    Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
    Muckenfuss H; Hamdorf M; Avots A; Sanzenbacher R; Tschulena U; Cichutek K; Flory E
    Mol Immunol; 2006 Mar; 43(8):1172-82. PubMed ID: 16125242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of the 120 kDa component of the human nuclear factor of activated T cells (NF-AT): reconstitution of binding activity to the cis-acting element of the GM-CSF and IL-2 promoter with AP-1.
    Tokumitsu H; Masuda ES; Tsuboi A; Arai K; Arai N
    Biochem Biophys Res Commun; 1993 Oct; 196(2):737-44. PubMed ID: 8240350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
    Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.
    Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K
    Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.
    Leung K; Nabel GJ
    Nature; 1988 Jun; 333(6175):776-8. PubMed ID: 2838755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of transcription of the interleukin-2 gene in B-lymphocytes].
    Mouzaki A; Zubler RH
    Schweiz Med Wochenschr; 1995 Mar; 125(9):396-9. PubMed ID: 7892566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line.
    Puri RK; Aggarwal BB
    Cancer Res; 1992 Jul; 52(13):3787-90. PubMed ID: 1617647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.
    Fortin JF; Barat C; Beauséjour Y; Barbeau B; Tremblay MJ
    J Biol Chem; 2004 Sep; 279(38):39520-31. PubMed ID: 15258149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin 2 gene expression: discrepancy between enhancer activity and endogenous gene expression.
    Mårtensson IL; Leanderson T
    Eur J Immunol; 1989 Jan; 19(1):145-9. PubMed ID: 2537733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat.
    Li JC; Lau AS
    Immunology; 2007 Jul; 121(3):337-48. PubMed ID: 17376198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of novel IL-2 transcriptional inhibitors.
    Baine Y; Stankunas BM; Miller P; Hobbs C; Tiberio L; Koch J; Yoon K; Sawutz D; Surowy C
    J Immunol; 1995 Apr; 154(8):3667-77. PubMed ID: 7706710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.